Fact sheet: Aviva AXA Fram Health Pn

Fund information
Fund name
Aviva AXA Framlington Health Pn S6
Fund manager company
Aviva Life & Pensions UK Ltd
Fund type
Pension Fund
Fund manager
  • Deane Donnigansince 06/04/2008
Underlying fund
AXA Framlington Health
Fund objective
Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies
Benchmark
  • MSCI World Healthcare
Investment style
No data available.
Investment method
No data available.
Quick stats
1 Year return
22.8%
1 Year rank in sector
156/520
Sector
PN Specialist
Yield
-
Fund size
£13m (£12m last year)
FE Risk score
?FE Risk Scores measure the riskiness of instruments relative to the FTSE 100 index of shares. Weekly volatility is measured over three years with recent behaviour counting more heavily than earlier behaviour. Cash-type investments will have scores close to zero. Funds will tend to have scores in the 0-150 range. The FTSE 100 is always scored at 100. There is no upper limit.
141
Bid price
389.17
Top in this sector
Fund name1 Year
OMW Neptune Rus + Grtr Rus76.2%
ReAssure AL NptRu&GtrRus Pn75%
L&G Nep Russia&Gtr Russia Pn74%
SIP Sanlam Gbl Fin Pn69.8%
OMW InvescoPerpetualEmgEurpn62%
...more in PN Specialist

Performance snapshot

Holdings snapshot

  • North America71.4%
    Europe ex UK13.7%
    UK10.1%
    Japan2.7%
    Global Emerging Markets1.1%
  • Biotechnology/Medical30.8%
    Pharmaceuticals27%
    Health Care19.9%
    Healthcare & Medical Products16.9%
    Hospital1.7%
  • North American Equities71.4%
    Europe ex UK Equities13.7%
    UK Equities10.1%
    Japanese Equities2.7%
    Global Emerging Market Equities1.1%

Performance vs Sector

Cumulative performance
 1 mth3 mth6 mth1 yr3 yr5 yr
Fund3.8%8%3.1%22.8%59.9%147.1%
Sector1.8%4.3%4%16.2%23.9%41.7%
Rank within sector57 / 55150 / 546252 / 541156 / 52018 / 3869 / 323
Quartile1st1st2nd2nd1st1st
Calendar performance
 YTD - 20172016201520142013
Fund5.9%9.1%12.1%32.5%35.3%
Sector2.1%11.6%2%7.2%11%
Rank within sector41 / 547269 / 51113 / 4476 / 3849 / 357
Quartile1st3rd1st1st1st
Risk statistics
Alpha
?Alpha is a measure of a fund's over- or under-performance by comparison to its benchmark. If the Alpha is 5, the fund has outperformed its benchmark by 5%; so the greater the Alpha, the greater the outperformance.
2.54
Beta
?Beta estimates a fund's volatility by comparison to that of its benchmark. A fund with a beta close to 1 means that the fund will move generally in line with the benchmark. Higher than 1 and the fund is more volatile than the benchmark and vice versa.
1.94
Sharpe
?This commonly-used measure calculates the level of return over and above the return of a notional risk-free investment, such as cash. The difference in returns is then divided by the fund's volatility. The resulting ratio is an indication of the amount of excess return generated per unit of risk.
0.84
Volatility
?Volatility (or standard deviation), when applied to an investment fund, expresses its risk. It shows how widely a range of returns varied from the fund's average return over a particular period. For example, if a fund had an average return of 5%, and its volatility was 15, this would mean that the range of its returns over the period had swung between +20% and -10%.
15.48
Tracking error
?This measures the standard deviation of a fund's excess returns over the returns of an index or benchmark portfolio. As such, it can be an indication of 'riskiness' in the manager's investment style. A Tracking Error below 2 suggests a passive approach. At 3 and above the the manager will be deploying a more active investment style.
11.64
Information ratio
?This is a useful risk-adjusted measure of actively managed fund performance. It is calculated by deducting the returns of the fund's benchmark from the fund's overall returns, then dividing the result by its tracking error. The higher the Information Ratio the better. It is generally considered that a figure of 0.5 reflects a good performance, 0.75 very good, and 1.00 outstanding.
0.74
R-Squared
?An indication of how closely correlated a fund is to an index or a benchmark. Values for R-Squared range between 0 and 1, with 0 indicating no correlation at all and 1 showing a perfect match. Values upwards of 0.7 suggest that the fund's behaviour is increasingly linked to its benchmark.
0.56
Price movement
52 week high392.31
52 week low303.92
Current bid price389.17
Current offer price-
Current mid price-
Region
1North America71.44%
2Europe ex UK13.66%
3UK10.14%
4Japan2.72%
5Global Emerging Markets1.11%
6Money Market0.93%
Industry sector
1Biotechnology/Medical30.83%
2Pharmaceuticals27.03%
3Health Care19.87%
4Healthcare & Medical Products16.9%
5Hospital1.71%
6Food & Drug Retailers1.48%
7Conglomerates1.25%
8Money Market0.93%
Asset type
1North American Equities71.44%
2Europe ex UK Equities13.66%
3UK Equities10.14%
4Japanese Equities2.72%
5Global Emerging Market Equities1.11%
6Money Market0.93%
Individual holdings
1ROCHE HLDG AG4.9%
2UNITEDHEALTH GROUP INC4.8%
3GLAXOSMITHKLINE4.5%
4CELGENE CORP4.3%
5ALLERGAN PLC4.2%
6GILEAD SCIENCES INC4.2%
7AMGEN INC3.3%
8MEDTRONIC INC3.3%
9LILLY (ELI) & CO3.1%
Management
Fund manager group
Aviva
Fund manager company
Aviva Life & Pensions UK Ltd
Fund type
Pension Fund
Fund objective
Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies
Benchmark
  • MSCI World Healthcare
Investment style
No data available.
Investment method
No data available.
Fund manager
NameSinceBiography
Deane Donnigan06/04/2008Deane joined AXA Framlington in October 1997. She currently manages the AXA Framlington Health Fund and AXA Framlington Biotech Fund. Deane attended University of Georgia and the Medical College of Georgia, spending seven years working as a pharmacy intern and a registered pharmacist while working on her BS and PharmD degrees. After this, she worked for 2 years at the Medical College of Georgia Hospital and Clinics with paediatric and adult patients. In 1990, Deane accepted a position with Emory University Hospital, Atlanta, Georgia, as a clinical specialist.
Compliance
No data available.
Domicile
No data available.
Fund for sale in
United Kingdom
Aviva AXA Framlington Health Pn Inet
Initial charge-
Annual charge0.6%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)-
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price348.75
CurrencyGBX
Price updated23/02/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeBEI8
Aviva AXA Framlington Health Pn S6
Initial charge-
Annual charge0.6%
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)-
Total expense ratio (TER)-
Bid price389.17
Offer price-
Mid price-
CurrencyGBX
Price updated23/02/2017
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeBEI7
Data provided by

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Financial Express. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.